ZNF100, a zinc finger protein involved in transcriptional regulation, currently does not have established pharmacogenetic interactions with specific drugs, despite its potential role in gene expression and regulation which could impact drug efficacy and safety. No direct evidence links ZNF100's function with the pharmacokinetics or pharmacodynamics of specific medications, and it has not been identified in known disease pathways or drug responses in clinical settings.